Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation

European Journal of Ophthalmology

Volumn 12, Issue 2, 2002, Pages 131-134

  Incorvaia, C ^a   Bandello, F ^a   Parmeggiani, F ^a   D'Angelo, S ^a   Costagliola, C ^a   Sebastiani, A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Factor V Leiden; Hereditary thrombophilia; Recurrent central retinal vein occlusion

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; PROTHROMBIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TEST; BLOOD VESSEL OCCLUSION; CAPILLAROSCOPY; CARDIOVASCULAR DISEASE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; DNA DETERMINATION; FEMALE; FOLLOW UP; GENE MUTATION; HETEROZYGOSITY; HLA TYPING; HUMAN; POLYMERASE CHAIN REACTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RECURRENT DISEASE; RESTRICTION MAPPING; SERODIAGNOSIS; THROMBOPHILIA; FLUORESCENCE ANGIOGRAPHY; GENETICS; HISTOCOMPATIBILITY TEST; NUCLEOTIDE SEQUENCE; POINT MUTATION; RETINA VEIN OCCLUSION; VISUAL ACUITY;

ADULT; ANTICOAGULANTS; CASE REPORT; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; FLUORESCEIN ANGIOGRAPHY; HISTOCOMPATIBILITY TESTING; HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; RECURRENCE; RETINAL VEIN OCCLUSION; THROMBOPHILIA; VISUAL ACUITY; WARFARIN; HUMANS;

EID: 0036014922     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Epidemiology of retinal vein occlusion and its association with glaucoma and increased ocular pressure
2. Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in patients with central retinal vein occlusion
3. Bilateral retinal vein occlusion associated with 5,10-methylene tetrahydrofolate reductase mutation
4. Idiopathic central retinal vein occlusion in a thrombophilic patient with heterozygous 20210 G/A prothrombin genotype
5. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study
6. Mutation in the coagulation factor V associated with resistance to activated protein C
7. Factor V Leiden, activated protein C resistance, and retinal vein occlusion
8. World distribution of factor V Leiden
9. The roles of protein C and thrombomodulin in the regulation of blood coagulation
10. The risk of recurrent venous thromboembolism in patients with an Arg506-Gln mutation in the gene for factor V (factor V Leiden)
11. Inherited predisposition to thrombosis
12. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
13. Risk factors for retinal vein occlusions. A case-control study
14. Risk factors for central retinal vein occlusion
15. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular risk
16. Plasma endothelin-1 concentrations in patients with retinal vein occlusions
17. Factor V antithrombin gene mutations in patients with idiopathic central retinal vein occlusion
18. Prevalence of factor V Leiden in young adults with retinal vein occlusion
19. Prevalence of factor V Leiden in patients with retinal vein occlusion
20. Familial thrombophilia and retinal vein occlusion
21. Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion
22. Heritable thrombophilia and hypofibrinolysis. Possible cause of retinal vein occlusion
23. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion
24. Central vein retinal thrombosis associated with resistance to activated protein C
25. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance